Hematopoietic Stem-Cell Transplantation in the Developing World: Experience from a Center in Western India

Table 7

Outcome parameters of our autologous and allogeneic patients till April 2014 after a median follow-up of 39 months.

Outcome data	Autologous	Allogeneic
(1) Median engraftment day (Range)	15 days (10–35 days)	14 days (9–34 days)
(2) Median posttransplant hospital stay (range)	18 days (10–80 days)	20 days (14–70 days)
(3) Mortality rate	30-day mortality: = 0; 100-day mortality: = 1; 1-year mortality: = 7; 3-year mortality: = 12; 39-month (median follow-up) mortality: = 12; Current mortality: = 14	30-day mortality: = 0; 100-day mortality: = 3; 1-year mortality: = 6; 3-year mortality: = 6; 39-month (median follow-up) mortality: = 6; Current mortality: = 6
(4) Current disease status	Complete remission: = 16; Partial remission: = 2; Relapse but alive: = 3	Complete remission: = 7; Partial remission: = 0; Relapse but alive: = 2
(5) OS at median (39 months) follow-up	65.7% ( = 23)	57.1% ( = 8)